Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Inauguration of Honesty Cosmetics Bar at Kumar Organics
    8 October 2024

    Inauguration of Honesty Cosmetics Bar at Kumar Organics

    Kumar organic Products Limited has inaugurated Honesty Cosmetics Bar at its Head Office in Jayanagar, Bangalore. Products displayed there are from Skin care, Hair care & Various formats of Depilatories. There are two Innovations too displayed they are Hair Wipe & Depilatory Tablet.
  • 4 October 2024
    CDSCO under Ministry of Health & Family Welfare becomes Affiliate Member of the International Medical Device Regulators Forum

    The Ministry of Health and Family Welfare has introduced comprehensive regulations for medical devices aimed at aligning the country's regulatory framework with globally accepted standards. This initiative seeks to foster a regulatory ecosystem that promotes growth and innovation in the medical device sector.

  • 4 October 2024
    Mankind Pharma to acquire Bharat Serums from Advent International for Rs 13,630 cr
    Mankind Pharma Limited has entered into a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines Limited from Advent International, one of the world’s largest and most experienced private equity investors, for an enterprise value of approx. INR 13,630 Crores, subject to closing related adjustments, the company said in a statement on exchanges.
  • 4 October 2024
    Dr. Reddy’s Lab signs agreement with Gilead Sciences to manufacture and commercialise Lenacapavir

    Dr. Reddy’s Laboratories Ltd. announced that it has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead Sciences Ireland UC for the manufacture and commercialisation of the drug, Lenacapavir, in India and 120 other countries.

  • 3 October 2024
    9th edition of Complete Companion for GPAT and Other Competitive Examination in Pharmacy published

    Dear All
    Most awaited and popular book with its latest 9th edition of Complete Companion for GPAT and Other Competitive Examination in Pharmacy published by Pearson Publication.
    For Purchase of Book Click on

    Features of book
    • All Important Theory for GPAT and other examinations in tabular, table as well as point form
    • More than 5000 Chapter wise MCQs
    • Dedicated NIPERJEE special module
    • Past Year Solved GPAT papers
    • Government Pharmacist, Drug inspector and Assistant Professor recruitment examination solved paper

  • 30 September 2024
    Scientists discover gene responsible for rare, inherited eye disease
    Scientists at the National Eye Institute and their colleagues have identified a gene responsible for some inherited retinal diseases, which are a group of disorders that damage the eyes light-sensing retina and threatens vision. Though IRDs affect more than 2 million people worldwide, each individual disease is rare, complicating efforts to identify enough people to study and conduct clinical trials to develop treatment.
  • 30 September 2024
    Scientists design new drug to fight malaria
    A team led by scientists at UC Riverside, UC Irvine, and Yale School of Medicine has now designed a new drug against malaria and identified its mechanism of action. The researchers found the drug, called MED6-189, is effective against drug-sensitive and drug-resistant P. falciparum strains in vitro as well as in a humanized mouse model the mice were engineered to have human blood.
  • 27 September 2024
    FDA approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    The U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.

  • 27 September 2024
    Torrent Pharma refutes claims of Shelcal 500 allegedly failing CDSCO quality test
    Recent articles have been issued in media with reference to the Central Drugs Standard Control Organization East Zone, Kolkata report referring to one batch sample of Product Shelcal 500, amongst other drugs marketed by various pharmaceutical companies, allegedly being non-standard quality.
  • 27 September 2024
    Top brands of paracetamol, pantoprazole, amoxycilin amongst failed sample, says CDSCO

    CDSCO reported top brands of paracetamol, pantoprazole, amoxicillin and other amongst failed samples reported by CDSCO. These samples are reported to be not of standard quality. Total 59 different brands from well known pharmaceutical industries failed to compile with standard quality.

    Top brands like Clavam 625, Mexclav 625, Shelcal, Pan D failed various assays and quality tests, which were collected and tested by different Drugs Testing Laboratories.

Subscribe to Pharma News